Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview
- 21 May 2013
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 10 (9), 1223-1237
- https://doi.org/10.1517/17425247.2013.796360
Abstract
Introduction: An ideal ophthalmic formulation is one that not only prolongs the contact time of the vehicle on the ocular surface but also slows down the drug elimination. The poor bioavailability and therapeutic response exhibited by the conventional ophthalmic solutions due to pre-corneal elimination of the drug may be overcome by the use of in situ gel forming systems. In situ gelling systems increase the viscosity by changing the pH or temperature in the pre-corneal region and lead to an increase of drug bioavailability by slowing drainage. Poloxamers are polyols with thermal gelling properties which are frequently included in ophthalmic formulations to improve the ocular bioavailability of drugs by increasing vehicle viscosity. Areas covered: An overview on the unique physiological characteristics of ocular globe and the limitations and disadvantages of the conventional ophthalmic pharmaceutical formulations. Readers will appreciate the different strategies to improve the absorption of drugs in the ocular globe, especially the incorporation of poloxamers in ophthalmic formulations, understanding the main advantages of the poloxamers and also learning about the different examples of applications of these polymers in ophthalmic pharmaceutical formulations. Expert opinion: Poloxamers offers a new strategy to improve bioavailability and decrease the side effects induced by the systemic absorption of topically applied ophthalmic drugs.Keywords
This publication has 55 references indexed in Scilit:
- Ocular Anatomy and Cross-Sectional Imaging of the EyeSeminars in Ultrasound, CT and MRI, 2011
- Ocular anatomy and physiology relevant to anaesthesiaAnaesthesia & Intensive Care Medicine, 2010
- Microparticle systems based on polymer-drug interaction for ocular delivery of ciprofloxacin I. In vitro characterizationJournal of Drug Delivery Science and Technology, 2007
- The use of mucoadhesive polymers in ocular drug deliveryAdvanced Drug Delivery Reviews, 2005
- The Ocular Surface and Tear Film and Their Dysfunction in Dry Eye DiseaseSurvey of Ophthalmology, 2001
- Anatomy of the eye and orbitCurrent Anaesthesia & Critical Care, 2000
- Physiological functions of the eyeCurrent Anaesthesia & Critical Care, 2000
- Ophthalmic drug delivery systems—Recent advancesProgress in Retinal and Eye Research, 1998
- Delivery of drugs to the eye by topical applicationProgress in Retinal and Eye Research, 1996
- The structural basis of the blood-ocular barriersExperimental Eye Research, 1977